Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of e...
Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
About this item
Full title
Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Intensive care medicine, 2018-03, Vol.44 (3), p.399-400
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Alternative Titles
Full title
Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_04314015v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04314015v1
Other Identifiers
ISSN
0342-4642
E-ISSN
1432-1238
DOI
10.1007/s00134-018-5068-1
